Dr Enrique Grande (MD Anderson Cancer Center Madrid, Madrid, Spain), Prof Syed Hussain (The University of Sheffield, Sheffield, UK), Dr Patrizia Giannatempo (Istituto Nazionale dei Tumori, Milan, Italy) and Dr Félix Guerrero-Ramos (Hospital Universitario 12 de Octubre, Madrid, Spain) discuss the latest in precision medicine in bladder cancer.

The panel explores recent clinical data demonstrating advances in personalised therapy and examines how modern treatment sequencing—including neoadjuvant, adjuvant, and maintenance strategies are evolving to improve outcomes.

The discussion focuses on optimising second-line and later treatment options to maximise patient benefit, with an emphasis on the growing real-world impact of biomarker-driven decision-making.

The panel also highlights emerging therapies and innovative combination regimens designed to enhance efficacy while preserving patient quality of life.